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In tÌris review, the vitamin C trials with military personnel and
with other subjects living under conditions comparable to
those of military recruits are analyzed to find out whether
vitamin C supplementation affects respiratory infections. For
this systematic review, we identified seven trials with military
personnel, three trials with students in crowded lodgings, and
two trials with marathon runners. Eight of these trials were
double blind and placebo controlled and seven were random-
ized. Five small trials found a statistically significant 45 to 9l%
reduction in common cold incidence in the vitamin C group.
These trials were short and the participants were under heavy
exertion during the trial. Furthermore, three otler trials found
a statistically significant 80 to 100% reduction in the inci-
dence of pneumonia in the vitamin C group. The large number
of positive findings seems to warrant further consideration of
the role of vitamin C in respiratory infections, particularþ in
military recruits.
Introduction
A high incidence of pneumonia ând other respiratory infec-
la.tions is a common problem among military recruits, possi-
bly caused by the crowding together of young adults from widely
dispersed geographic areas.r-'Naly and Marine recruits were at
30 times higher risk of hospital admission for pneumonia than
vr'ere nonrecruits,l and Navy and Marine personnel with less
than I year of service were at fìve times higher risk of pneumo-
nia than their peers with 4 or more years of service.a Conse-
quently, factors affecting susceptibility to respiratory infections
in military recruits are of considerable practical importance.
The notion that vitamin C affects susceptibility to various
infections-and respiratory infections in particular-is an old
one,5'6 but the topic came to wider popularity only in the 1970s,
when PaulingT,s suggested that vitamin C supplementation
would reduce the incidence and severity of colds. Trials canied
out since then have consistently found that vitamin C alleviates
common cold symptoms, but yields only modest benefit.e-t2 Vi-
tamin C had no effect on the incidence of the common cold in the
largest ûia1s,6,r2,13 but trials with British menrs and with sub-
jects under heavy, acute physical stressra found reduction in
common cold incidence, sugesting that vitamin C affects sus-
ceptibility to respiratory infections in restricted groups of peo-
ple. Although Paulingwas considerably overoptimistic about the
potential benefits of vitamin C,7'8'1r-r3 another problem in this
area of interest has been the negative bias against vitamin C.
Three influential reviews concluded that vitamin C is ineffective
against colds; however, the reviews presented data inconsistent
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with the original reports, overlooked several highly relevant fìnd-
ings, and anaþed data inappropriately.e'r0
The purpose of the present reviewwas to analyze the fìndings
of vitamin C trials with military personnel and of trials with
participants under conditions similar to those of military re-
cruits to find out whether vitamin C affects the incidence or
severity of respiratory infections.
Methods
Selection of the Trials
I previously searched the literature on vitamin C and respira-
tory infections using various MEDLINE, EMBASE, and
SCISEARCH database searches, and I inspected the reference
lists of reviews and original reports.6'Il'r3 One other author in-
dependently searched for trials on vitamin C and the common
cold and published the identified bibliography.rs For this sys-
tematic review, further MEDLINE searches covering the years
1999-2002 were carried out.
The present review covers only controlled trials in which
yitamin C was administered to one study group; the control
group may or may not have received a placebo. This analysis
focused on trials reporting respiratory tract infection out-
comes. Two groups of trials were selected on the basis of
subjects used in the trials: military personnel (seven trials;
Table I) and students accommodated in crowded lodgings and
marathon runners (five trials; Table II). Except for one trial,rs
the trials in the tables are prophylactic such that participants
were healthy at the trial's outset and supplementation con-
tinued over the occurring respiratory infection episodes. Al-
though one trial examined patients hospitalized for influenza
A, it was nevertheless prophylactic with respect to the occur-
rence of pneumonia after the initiation of vitamin C supple-
mentation.ls
Statistical Methods
Tables I and II show the p values calculated by the current
author for the differences in the outcome values between the
two groups. For dichotomous data, the mid-p modification2s
of the Fisher's exact test2e was used to calculate p. For con-
tinuous variables, the exact p value was calculated using the
t test,2e when mean and SD were reported in the original
articles. The f test2e was used to test whether the distribu-
tion of participants with correct and incorrect answers in the
Pitt and Costrini triallG is explained by random variation.
Assuming pure guessing, the expected number of correct and
wrong answers is equal; both are one-half of all of the an-
swers. Consequently, with 316 answers'in the Pitt and Cos-
trini trial, the expected number of correct and wrong answers
is 158.
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Vitamin C Supplementation and Respiratory Infections
TABLD I
VITAMIN C AND RESPIRATORY INFECTIONS IN MILITARY PERSONNEL
o Reflects country, dose ofvitamin C, and duration, respectively.
b The p values were calculated by this author, except for the Elliott data. Elliott used the Wilcoxon test to calculate p. -, Data not published.
" Difference between the treatment groups: p was calculated from I (15 dj = 27 .8 reported by Pitt and Costrini.l6 Severity scale is from 1 to 4.
d Pneumonia, bronchitis, sinusitis, tonsilitis, and otitis media.
" General malaise, headache, chills and fever, and vomiting.
The one-tailed p values are used in the tables and text be-
cause the explicit question in the present analysis is whether
vitamin C supplementation decreases the incidence and severity
ofrespiratory infections. There is no experimental or theoretical
reason to expect that vitamin C supplementation would increase
morbidity from respiratory infections. Confidence intervals are
not calculated because the primary purpose of this review was
to test the hypothesis that vitamin C affects respiratory infec-
tions. Trial settings and outcome defìnitions vary substantially,
which limits the possibility to generalize the point estimates;
therefore, no pooled estimates were calculated,
lrials with Military Personnel
Seven trials examined the effect of vitamin C supplementa-
tion on respiratory infections in military personnel. Table I
shows the number of participants, the duration of the trial,
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the dosage of vitamin C, and the outcome values. There is
substantial variation in the common cold incidence in the
control groups. Pitt and Costrinilo observed ll colds per per-
son-year, whereas Dahlberg et aI.17 observed only 0.4 colds
per person-year, although both of these large trials examined
military recruits.
Pitt and Costrinit6 canied out a large-scale, randomized, dou-
ble-blind, placebo-controlled trial with Marine recruits in a train-
ing camp in South Carolina in the wintertime. The participants
were vaccinated against adenovirus and influenzâ, and they re-
ceived penicillin or erythomycin as streptococcal prophylaxis. The
study groups showed no difference in common cold incidence.
Vitâmin C caused a statistically significant, althougþ clinically
minor, reduction in common cold severity. Of the eight pneumonia
cases observed, five were caused by fneumococcus but two of
them had a coinfection with parainfluenza virus. The incidence of
pneumoniawas significanfly lower in the vitamin C group.
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TABLE tr
VITAMIN C AND RESPIRATORY INFECTIONS IN STUDÐNTS ACCOMMODATED IN CLOSED SUARTERS AND IN MARATHON RUNNERS
" Reflects country, location/subjects, dose ofvitamin C, and duration, respectively.
b The p values were calculated by this author, except for the Ritzel data for the duration of colds, for which Ritzel used the t test.
" Diseases caused by hemolytic streptococci: sore throat, pharyngitis, tonsillitis, cervical adenitis, and otitis media. Throat swabs were taken of
large numbers of patients to determine that the causative agent was hemolytic streptococcus.
d General malaise, headache, muscle ache, abdominal pain, vomiting, and diarrhea.
Interestingþ, Pitt and Costrinir6 also found that a consider-
able proportion of their participants colrectly inferred their
treatment from subjective observations (for a comparable case,
see Ref. l0). When asked which pill they thought they were
taking, 530/o (358) of all participants (674) stated they did not
know. Of those who replied vitamin C or placebo (316), 27% (Bg)
and 260/o (89) answered correctly, \r/hereas 200/o (66) and 210/o
(72) answered incorrectly in the vitamin C and placebo groups,
respectively. Consequently, in all, 178 participants answered
correctly and l3B incorrectly. Assuming pure guessing, the ex-
pected number of correct and incorrect answbrs is 158, which
allows the calculation of observed and expected difference to
yield l(1 dJl = 5.0 and p[one-tai¡ = 0.013. Consequently, 40
participants (I7B - l3B) correctly inferred their treatment in
this double-blind trial. Formulated from citric acid, the placebo
tablets were indistinguishable in appearance and taste from the
ascorbic acid tablets. Therefore, it is worth noting that 6%o (40 of
674) of all participants inferred their treatment by subjective
perception alone.
Dahlberg et a1.17 performed a large-scale, double-blind, pla-
cebo-controlled trial with infantry recruits in Northern Sweden
in the wintertime. Allocation to the study groups was by odd and
even identity numbers. Low doses of vitamin C had no effect on
the number of parlicipants who caught the common cold. How-
ever, the number of participants in the vitamin C group with
more severe respfatory infections \¡/as only one-half that of the
placebo group level, although the difference was not statistically
signifìcant.
Kimbarowski and Mokrowls carried out a thempeutic trial in
the former Soviet Union with military persorìnel hospitalized for
influenza A infections, The method of allocation was not de-
scribed and placebo was not used. Nevertheless, the distribu-
tion of influenza severity in the vitamin C and control groups
was similar, indicating that the groups were comparable in this
respect. The authors focused primarily on the usefulness of a
laboratory test in evaluating the sevêrity'of uncomplicated in-
fluenza and excluded from further studies those particþants
who caught pneumonia during vitamin C supplementation. The
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number of pneumonia cases was reported and it was signifi-
cantly lower in the vitamin C group. The authors were uninter-
ested in pneumonia per se, and therefore the placebo effect and
information bias'u seem unlikely explanations for the reported
difference,
Kimbarowski and Mokrowts also noted that most vitamin C
patients were released on the 9th day of illness, whereas the
control patients were released 2 to 3 days later, mostly on the
l2th day of illness. However, the authors failed to publish the
actual mean and SD, thus p cannot be calculated for the stay in
hospital.
Sabiston and Radomskile carried out a small randomized,
double-blind, placebo-controlled trial with troops on a winter
exercise in Northern Canada. The vitamin C group saw not only
significantly fewer common cold episodes, but also a signifi-
cantly shorter duration of constitutional symptoms as well.
Moreover, it is worth noting the uneven distribution of colds in
the 14 tents. There was at least one cold in nine tents: six tents
had colds onþ in the placebo subjects, and three tents had colds
in the placebo and vitamin C subjects, but no tents had colds
only in the vitamin C subjects.te Accordingly, vitamin C ap-
peared to increase resistance against colds so that vitamin C
subjects fell ill only if exposed to infected placebo subjects
within the same tents but not if exposed to infected subjects
outdoors.le'30
Ðlliott2o carried out a small randomized, double-blind, place-
bo-controlled trial in a Polaris submarine. Vitamin C had no
effect on common cold incidence, but Elliott failed to report
explicit data. Neverthe.less, the vitamin C group saw fewer days
of morbidity for productive and nonproductive cough, hoarse-
ness, and sore throat. The effect on productive cough and sore
throat was statistically signifìcant.
Liljefors2 I performed a small randomized, placebo-controlled,
double-blind cross-over trial in Sweden in the autumn. The
subjects participated in military repetition exercise and were
considerably older than ordinary recruits (mean age 36 years in
the Liljefors trial). Vitamin C had no effect on common cold
incidence in this small and short trial.
Niemi22 failed to describe properþ the technical aspects of his
trial with military recruits in two garrisons in Southern Finland.
The number of observed common cold episodes was small, lead-
ing to low statistical power to observe moderate treatment ef-
fects. The low dosage of vitamin C did not reduce the number of
common cold episodes.
Trials with Students in Crowded Lodgings and with
Marathon Runners
For this review, the most essential criteria among military
recruits are their age and the crowded nature of their accom-
modations, which regularly subjects them to close contact with
each other. Three vitamin C trials with students residing in
closed and crowded lodgings share these same criteria (Table II).
An additional criterion typical of military recruits is their fre-
quent healy physical exertion, which arises interest in trials
with marathon runners as well (Table II).
Glazebrook and Thomson23 carried out a large-scale trial with
male students (15-20 years old) in a boarding school in Scot-
land. For practical reasons, the participants were not randomly
allocated to the study groups, but certain administrative divi-
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sions occupying the same tables in the dining room were served
vitamin C-supplemented food, whereas others remained as con-
trols. There was, however, a fair amount of mixing of the dining
divisions in the sleeping quarters. The authors reported that a
tonsillitis epidemic affected all of the dining divisions uniformly
the year before, suggesting that the divisions should not be
regarded as separate units. Because vitamin C was added to the
food in the kitchen, the placebo effect does not seem a relevant
concem, although no placebo powderwas used. Vitamin C sup-
plementation continued even when a student fell so ill that he
was admitted to the hospital.
Glazebrook and Thomson23 found a statistically signifìcant,
but clinically minor, reduction in common cold incidence by
vitamin C, but they observed a greater effect in the number of
youths hospitalized for severe colds. In the control group ,23.00/o
of participants were admitted to the hospital because of severe
colds, whereas in the vitamin C group, only 17.60/o of partici-
pants were hospitalized for colds. Accordingly, 5.4%o of vitamin
C subjects obtained benefit for this outcome. There was no
difference in the incidence of streptococcal infections, but fewer
vitamin C participants were hospitalized, and their stay at the
hospital was on average significantly shorter than those in the
control group. Finally, no cases of pneumonia or rheumatic
fever occurred in the vitamin C group, whereas several cases
occurred in the control group. Although this was not a double-
blind, placebo-controlled trial, the placebo effect and informa-
tion bias28 fail to explain easily the findings for the hospital stay
or the dramatic difference in the incidence of pneumonia and
rheumatic fever. In particular, the duration of treatment in the
hospital was completely beyond the authors' control.
RitzelT'24 performed a short, random2ed, double-blind, place-
bo-controlled trial with male hlgh school students (15-17 years
old) at a skiing camp in the Swiss Alps. Vitamin C significantly
reduced the incidence and duration of colds. Furthermore, the
vitamin C group saw substantially fewer days with constitu-
tional symptoms.
Bessel-Lorck25 carried out a small and short trial with high
school students (14-16 years old) at a skiing camp in the Ba-
varian mountains. The control group received no placebo, and
the allocation method was not described. The vitamin C group
experienced a significantly lower incidence of colds.
Peters et a1.26,27 carried out two randomized, double-blind,
placebo-controlled trials in South Africa with marathon run-
ners. The number ofcolds recorded during a 2-week period after
the race indicated that vitamin C supplementation before the
race signifìcantþ reduced the number of colds after the race,
but had no effect on the duration of s¡rmptoms.
Effect of Vitamin C on the Common Cold and
Pneumonia
Three of the trials involved a large number of partici-
pânfs.r6'tz'23 In two of these large-scale trials, vitamin C had no
effect on common cold incidence.16'17'Ihe third trial, carried out
in the United Kingdom, found a statistically significant, but
rather small, reduction in common cold incidence,ls'23 but a
somewhat greater effect on hospita-lization for colds, These
large-scale trials suggest that any potentially important effects
of vitamin C supplementation on common cold incidence are
restricted to specific groups of subjects and conditions.
Military Medicine, Vol. 169, November 2004
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Five small trials found significant reduction in the incidence
of colds with vitamin C. " 'n-" Al1 of these trials were shori, lasting
at most a fewweeks, and the subjects underwent extraordinary
conditions involving heavy acute physical stress.ra Healy exer-
tion has been associated with the speeding up ofthe depletion of
the vitamin C pool and with causing a frank deficiency when
dietary vitamin C intake is low.31 In this respect, heavy exertion
is an interesting element that these five small trials have in
common. TWo of these trialsle'24 reported a significant effect of
vitamin C on the constitutional s1'rnptoms of the common cold,
such as general malaise and headache, but a smaller effect on
the duration of mild symptoms. Three additional small trials
found thatvitamin C supplementation had no effect on common
cold incidence.2o-22 These latter trials involved no extraordinary
exertion, setting them apart from the former set.
'lVo large-scale trialsr6'23 found evidence indicating that vita-
min C supplementation may affect the risk of pneumonia. None-
theless, it is noteworthy that the incidence of pneumonia was
exceptionally high in the control groups of Pitt and Costrinil6
and Glazebrook and Thomson:23 120 and 30 cases per 1,000
person-years, respectively. In comparison, the average inci-
dence of pneumonia in Marine and Naval recruits in the 1970s
was also high, 60 per 1,000 person-years, whereas the incidence
in young nonrecruits was only 2 per 1,000 person-years,r TWo
studies of young adults in Westem countries reported an inci-
dence of pneumonia of I to 4 per 1,000 person-yeals.32'33 Con-
sequently, the findings of Pitt and Costrinir6 and Glazebrook
and Thomson23 cannot be generalized to the population of ordi-
nary young adults, bgt may have relevance to populations at
high risk of pneumonia, such as military recruits.
Furthermore, Kimbarowski and Mokrowrs observed a reduced
risk of pneumonia in influenza patients and Dahlberg et a1.17
reported 50% lower incidence of respiratory infections more
severe than the common cold in their vitamin C group, but the
difference was not statistically significant.
Amount of Vitamin C in Diet and in Supplements
One particular problem in the interpretation of vitamin C
trials is the great variation in the dietary lntake levels and
supplementation dosages. A different value of outcome between
vitamin C and control groups may result from a particularly low
dietary intake in the control group ("marginal deficiency") or
from the high-dose supplementation in the vitamin C group. In
the former case, a small dosage of supplement might produce a
similar effect, whereas the latter case requires the particularly
high dosage, Previously, low dietary intake of vitamin C, rather
than high-dose supplementation, was proposed better to ex-
plain the decrease in common cold incidence found in trials with
British men.13
The trials in Tables I and II vary widely in dietary vitamin C
intake. Sabiston and Radomskile estimated that the food rations
contained at most 40 mg/day of vitamin C, which is consider-
ably lower than the current U.S. recommendation for men (90
mg/day).3a Pitt and Costrinil6 failed to estimate dietary vitamin
C intake, but in their subjects, the mean vitamin C level in
plasma was rather high initially, 57 p,mollL, corresponding to a
dietary intake of 100 mg/day or more.35 Glazebrook and Thom-
son23 estimated that their control students obtained only 15
mglday of vitamin C in foods. On the other hand, the control
Vitamin C Supplementation and Respiratory Infections
group of Peters et a1.26'27 received some 500 mg/day of vitamin C
from foods and self-supplementation. Thus, vitamin C intakes
among the control groups vary up to 3O-fold. The dosage of
supplements also varied dramatically, from 0.05 to 2 glday
(Tables I and II). Accordingly, the supplement dosages vary up to
40-fold.
Such dramatic variations in dietary vitamin C intakes and in
supplement dosages preclude any simple comparisons of the
trials inTables I and II and any straight generalizations to other
population groups, although all of the trials test whether vita-
min C supplementation affects respiratory infections.
Conclusions
Several trials with miliiary personnel and with participants
under conditions comparable to those of military recruits have
found that vitamin C substantially reduced the incidence or
severity ofrespiratory infections. Although there is greatvaria-
tion in the technical quality of the analyzed trials, eigþt of the
trials were double blind and placebo controlled. Furthermore,
the technical shortcomings in two less satisfactory trialsls'23 fail
to discount their fìndings.
The estimates of benefit calculated in Tables I and II require
cautious interpretation. If vitamin C does aÍfect respiratory in-
fections, it seems evident that no single estimate applies to all
population groups because various factors, such as the dietary
intake level of vitamin C, the dosage of supplements, the defi-
nition of outcome, and the level of exertion, most likely modiff
the effect. Consequenfly, the estimates presented in the tables
in all probability do not directly apply to other population
groups. Nevertheless, the large number of statistically signifì-
cant benefits observed in these trials seems to warrant further
examination of the role of vitamin C in respiratory infections,
particularly in military recruits.
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